Evaluation of the therapeutic efficacy of some antimuscarinics against soman in vivo

Journal of Applied Toxicology

Volumn 16, Issue 5, 1996, Pages 423-430

  Lau, Wai Man ^a   Lewis, Katie J ^a   Dawson, Raymond M ^a  

^a AERO AND MAR RESEARCH LABORATORY   (Australia)

Author keywords

Atropine; Blood cholinesterases; Glycopyrrolate; HI 6; Oximes; Protection ratio; Soman; Tacrine

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ACETYLCHOLINESTERASE; ATROPINE; CHOLINESTERASE; GLYCOPYRRONIUM BROMIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; SOMAN; TACRINE;

ANIMAL MODEL; ARTERIAL PRESSURE; CHOLINESTERASE BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HEART RATE; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LETHALITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029740377     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(199609)16:5<423::AID-JAT367>3.0.CO;2-Z     Document Type: Conference Paper

References (28)

1. W.-M. Lau and S. E. Freeman, An analysis of the depressant effects of soman on the guinea-pig atrium. Asia Pacific J. Pharmacol. 4, 17-24 (1989).
2. W.-M. Lau, Protection by tacrine and some adjuncts against the depressant effects of soman in guinea-pig atrium. Gen. Pharmacol. 24, 1513-1519 (1992).
3. C. Chassaing, M. Boucher, C. Breysse and P. Duchene-Marullaz, Contribution of vagal blockade to the tachycardia induced by the antimuscarinic agents atropine and pirenzepine. J. Auton. Pharmacol. 12, 359-368 (1992).
4. J. W. Amshey, G. M. Steunberg and R. B. Miller, A screening program for selective inhibitors of the phosphorylation of acetylcholinesterase. Edgewood Arsenal Technical Report EB-TR-73014, MD, USA (1973).
5. J. Bajgar, J. Patocka, J. Fuzek and V. Hrdina, Some possibilities of protection against acetylcholinesterase inhibition by organophosphates in vivo. Sb. Ved. Pr. Lek. Fak. Karlovy Univ. Hradci Kralove 27, 425-435 (1984).
6. A. Galli and F. Mori, Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication. Arch. Toxicol. 65, 330-341 (1991).
7. K. -B. Augustinsson, H. Eriksson and Y. Faijersson, A new approach to determining cholinesterase activities in samples of whole blood. Clin. Chim. Acta 89, 239-252 (1978).
8. A. J. Hunter, T. K. Murray, J. A. Jones, A. J. Cross and A. R. Green, The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro. Br. J. Pharmacol. 98, 79-86 (1989).
9. P. Hartvig, H. Askmark, S. M. Aquilonius, L. Wiklund and B. Lindstrom, Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine. Eur. J. Clin. Pharmacol. 38, 259-263 (1990).
10. J. H. Brown, Atropine, scopolamine and related antimuscarinic drugs. In The Pharmacological Basis of Therapeutics, 8th Edn, ed. by A. L. Gilman, T. W. Rall, A. S. Nies and P. Taylor, pp. 150-165. Pergamon Press, New York (1990).
11. C. G. Rousseaux and A. K. Dua, Pharmacology of HI-6, an H-series oxime. Can. J. Physiol. Pharmacol. 67, 1183-1189 (1989).
12. J. Kanto and U. Klotz, Pharmacokinetic implications for the clinical use of atropine, scopolamine and glycopyrrolate. Acta Anaesthesiol. Scand. 32, 69-78 (1988).
13. + channel by tacrine: interactions with muscarinic and adenosine receptors. Eur. J. Pharmacol. 154, 59-66 (1988).
14. J. A. Nielson, E. E. Mena, I. H. Williams, M. R. Nocerini and D. Liston, Correlation of brain level of 9-amino-1, 2, 3, 4,-tetrahydroacridine (THA) with neurochemical and behavioural changes. Eur. J. Pharmacol. 173, 53-64 (1989).
15. R. M. Dawson, Tacrine slows the rate of aging of sarin-inhibited acetylcholinesterase. Neurosci. Lett. 100, 227-230 (1989).
16. D. Benveniste, L. Hemmingsen and P. Juul, Tacrine inhibition of serum cholinesterase and prolonged succinylcholine action. Acta Anaesthesiol. Scand. 11, 297-309 (1967).
17. W. Osterrieder, 9-Amino -1,2,3,4-tetrahydroacridine (THA) is a potent blocker of caridac potassium channels. Br. J. Pharmacol. 92, 521-525 (1987).
18. R. I. Ellin, Anomalies in theories and therapy of intoxication by potent organophosphorus anticholinesterase compounds. Gen. Pharmacol. 13, 457-466 (1988).
19. R. F. Fricke, I. Koplovitz, B. A. Scharf and G. A. Rockwood, Efficacy of tacrine as a nerve agent pretreatment. Drug Chem. Toxicol. 17, 15-34 (1994).
20. S. E. Freeman and R. M. Dawson, Tacrine: a pharmacological review. Prog. Neurobiol. 36, 257-277 (1991).
21. J. G. Clements, S. Rosario, E. Bessette and N. Erhardt, Soman and sarin inhibition of molecular forms of acetylcholinesterase in mice. Time course of recovery and reactivation by the oxime HI-6. Biochem. Pharmacol. 42, 329-335 (1991).
22. Y. Kloog and M. Sokolovsky, Bisquaternary pyridinium oximes as allosteric inhibitors of rate brain and muscarinic receptors. Mol. Pharmacol. 27, 418-428 (1985).
23. B. P. Pearce and L. T. Potter, Effects of tetrahydroaminoacridine on M1 and M2 muscarinic receptors. Neurosci. Lett. 88, 281-285 (1989).
24. M. Szilagyi and W.-M. Lau, Interaction of tacrine at M1 and M2 cholinoceptors in guinea pig brain. Pharmacology 47, 223-229 (1993).
25. W.-M. Lau and M. Szilagyi, A pharmacological profile of glycopyrrolate: interactions at muscarinic acetylcholine receptor. Gen. Pharmacol. 23, 1165-1170 (1992).
26. M. Watson, W. R. Roeske, T. W. Vickroy, T. L. Smith, K. Akiyama, K. Gulya, S. P. Duckies, M. Serra, A. Adem, A. Nordberg, D. R. Gehlert, J. K. Wamsley and H. I. Yamamura, Mapping of subtypes of muscarinic receptors in the human brain with receptor autoradiographic techniques. Trends Pharmacol. Sci. Suppl. II, 46-55 (1985).
27. H.-H. Zhou, A. Adedoyin and A. J. J. Wood. Differing effect of atropine on heart rate in Chinese and White subjects. Clin. Pharmacol. Ther. 52, 120-124 (1992).
28. J. E. H. Tattersall, Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro. Br. J. Pharmacol. 108, 1006-1015 (1993).